|
Biological Activity:
Selective 5-HT6 antagonist; a potential agent added to stablize donepezil (Axon 1438) treatment in subjects with mild-to-moderate Alzheimer's disease.
References: online 1, 2, 3, 4
N Idris et al. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology 2010, 208 (1), 23–36. [online]
G Maher-Edwards et al. Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease. Curr. Alzheimer Res. 2009, 7(5), 374-385. [online]
G Rossé G and H Schaffhauser. 5-HT(6) Receptor Antagonists as Potential Therapeutics for Cognitive Impairment. Curr. Top. Med. Chem. 2010, 10(2), 207-221. [online]
N Upton et al. 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 2008, 5(3), 458–469. [online]
Chemical Name: 3-Benzenesulfonyl-8-piperazin-1-yl-quinoline trihydrochloride
|